[1]
|
Timmermans, S. and Libert, C. (2018) Learning Lessons in Sepsis from the Children. Molecular Systems Biology, 14, e8335. https://doi.org/10.15252/msb.20188335
|
[2]
|
Majno, G. (1991) The Ancient Riddle of Sigma Eta Psi Iota Sigma (Sepsis). The Journal of Infectious Diseases, 163, 937-945. https://doi.org/10.1093/infdis/163.5.937
|
[3]
|
Kumar, V. (2018) Targeting Macrophage Immunometabolism: Dawn in the Darkness of Sepsis. International Immunopharmacology, 58, 173-185. https://doi.org/10.1016/j.intimp.2018.03.005
|
[4]
|
Reinhart, K., Daniels, R., Kissoon, N., et al. (2017) Recognizing Sepsis as a Global Health Priority—A WHO Resolution. The New England Journal of Medicine, 377, 414-417. https://doi.org/10.1056/NEJMp1707170
|
[5]
|
American College of Chest Physicians/Society of Critical Care Medi-cine Consensus Conference: Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. Critical Care Medicine, 1992, 20, 864-874. https://doi.org/10.1097/00003246-199206000-00025
|
[6]
|
Bone, R.C., Balk, R.A., Cerra, F.B., et al. (1992) Defi-nitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101, 1644-1655. https://doi.org/10.1378/chest.101.6.1644
|
[7]
|
Levy, M.M., Fink, M.P., Marshall, J.C., et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine, 31, 1250-1256. https://doi.org/10.1097/01.CCM.0000050454.01978.3B
|
[8]
|
Vincent, J.L., Opal, S.M., Marshall, J.C., et al. (2013) Sepsis Definitions: Time for Change. The Lancet, 381, 774-775.
https://doi.org/10.1016/S0140-6736(12)61815-7
|
[9]
|
Balk, R.A. (2014) Systemic Inflammatory Response Syn-drome (SIRS): Where Did It Come from and Is It Still Relevant Today? Virulence, 5, 20-26. https://doi.org/10.4161/viru.27135
|
[10]
|
Kaukonen, K.M., Bailey, M., Pilcher, D., et al. (2015) Systemic Inflamma-tory Response Syndrome Criteria in Defining Severe Sepsis. The New England Journal of Medicine, 372, 1629-1638. https://doi.org/10.1056/NEJMoa1415236
|
[11]
|
Huang, M., Cai, S. and Su, J. (2019) The Pathogenesis of Sepsis and Potential Therapeutic Targets. International Journal of Molecular Sciences, 20, 5376. https://doi.org/10.3390/ijms20215376
|
[12]
|
Takeuchi, O. and Akira, S. (2010) Pattern Recognition Receptors and Inflammation. Cell, 140, 805-820.
https://doi.org/10.1016/j.cell.2010.01.022
|
[13]
|
D’Elia, R.V., Harrison, K., Oyston, P.C., et al. (2013) Targeting the “Cytokine Storm” for Therapeutic Benefit. Clinical and Vaccine Immunology, 20, 319-327. https://doi.org/10.1128/CVI.00636-12
|
[14]
|
Raymond, S.L., Holden, D.C., Mira, J.C., et al. (2017) Microbial Recognition and Danger Signals in Sepsis and Trauma. Biochimica et Biophysica Acta—Molecular Basis of Disease, 1863, 2564-2573.
https://doi.org/10.1016/j.bbadis.2017.01.013
|
[15]
|
Lamkanfi, M. (2011) Emerging Inflammasome Effector Mecha-nisms. Nature Reviews Immunology, 11, 213-220.
https://doi.org/10.1038/nri2936
|
[16]
|
Kawai, T. and Akira, S. (2010) The Role of Pattern-Recognition Receptors in Innate Immunity: Update on Toll-Like Receptors. Nature Immunology, 11, 373-384. https://doi.org/10.1038/ni.1863
|
[17]
|
Hagar, J.A., Powell, D.A., Aachoui, Y., et al. (2013) Cytoplasmic LPS Acti-vates Caspase-11: Implications in TLR4- Independent Endotoxic Shock. Science, 341, 1250-1253. https://doi.org/10.1126/science.1240988
|
[18]
|
Deng,, M., Tang, Y., Li, W., et al. (2018) The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis. Immunity, 49, 740-753. https://doi.org/10.1016/j.immuni.2018.08.016
|
[19]
|
Efron, P.A., Martins, A., Minnich, D., et al. (2004) Characteri-zation of the Systemic Loss of Dendritic Cells in Murine Lymph Nodes during Polymicrobial Sepsis. The Journal of Immunology, 173, 3035-3043.
https://doi.org/10.4049/jimmunol.173.5.3035
|
[20]
|
Cheng, S.C., Scicluna, B.P., Arts, R.J., et al. (2016) Broad De-fects in the Energy Metabolism of Leukocytes Underlie Immunoparalysis in Sepsis. Nature Immunology, 17, 406-413. https://doi.org/10.1038/ni.3398
|
[21]
|
Ma, Y., Zhou, Y., Wu, F., et al. (2019) The Bidirectional Interactions between Inflammation and Coagulation in Fracture Hematoma. Tissue Engineering Part B: Reviews, 25, 46-54. https://doi.org/10.1089/ten.teb.2018.0157
|
[22]
|
Biemond, B.J., Levi, M., Ten, C.H., et al. (1995) Plasminogen Ac-tivator and Plasminogen Activator Inhibitor I Release during Experimental Endotoxaemia in Chimpanzees: Effect of In-terventions in the Cytokine and Coagulation Cascades. Clinical Science (London), 88, 587-594. https://doi.org/10.1042/cs0880587
|
[23]
|
Rocha, M., Herance, R., Rovira, S., et al. (2012) Mitochondrial Dysfunc-tion and Antioxidant Therapy in Sepsis. Infectious Disorders—Drug Targets, 12, 161-178. https://doi.org/10.2174/187152612800100189
|
[24]
|
Quoilin, C., Mouithys-Mickalad, A., Lecart, S., et al. (2014) Evidence of Oxidative Stress and Mitochondrial Respiratory Chain Dysfunction in an in Vitro Model of Sepsis-Induced Kidney Injury. Biochimica et Biophysica Acta, 1837, 1790-1800. https://doi.org/10.1016/j.bbabio.2014.07.005
|
[25]
|
Hotchkiss, R.S., Swanson, P.E., Freeman, B.D., et al. (1999) Apoptotic Cell Death in Patients with Sepsis, Shock, and Multiple Organ Dysfunction. Critical Care Medicine, 27, 1230-1251.
https://doi.org/10.1097/00003246-199907000-00002
|
[26]
|
Maurer, K., Reyes-Robles, T., Alonzo, F.R., et al. (2015) Autophagy Mediates Tolerance to Staphylococcus aureus Alpha-Toxin. Cell Host & Microbe, 17, 429-440. https://doi.org/10.1016/j.chom.2015.03.001
|
[27]
|
Qiu, P., Liu, Y. and Zhang, J. (2019) Review: The Role and Mechanisms of Macrophage Autophagy in Sepsis. Inflammation, 42, 6-19. https://doi.org/10.1007/s10753-018-0890-8
|
[28]
|
Rhodes, A., Evans, L.E., Alhazzani, W., et al. (2017) Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine, 43, 304-377.
https://doi.org/10.1007/s00134-017-4683-6
|
[29]
|
Sterling, S.A., Miller, W.R., Pryor, J., et al. (2015) The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Criti-cal Care Medicine, 43, 1907-1915.
https://doi.org/10.1097/CCM.0000000000001142
|
[30]
|
Salmeri, M., Sorbello, M.G., Mastrojeni, S., et al. (2016) Infections of Cardiovascular Implantable Electronic Devices: 14 Years of Experience in an Italian Hospital. Le Infezioni in Medicina, 24, 131-136.
|
[31]
|
Shankar-Hari, M., Spencer, J., Sewell, W.A., et al. (2012) Bench-to-Bedside Review: Im-munoglobulin Therapy for Sepsis—Biological Plausibility from a Critical Care Perspective. Critical Care, 16, 206.
https://doi.org/10.1186/cc10597
|
[32]
|
Alejandria, M.M., Lansang, M.A., Dans, L.F., et al. (2013) Intravenous Im-munoglobulin for Treating Sepsis, Severe Sepsis and Septic Shock. Cochrane Database of Systematic Reviews, 2013, D1090.
https://doi.org/10.1002/14651858.CD001090.pub2
|
[33]
|
Rossmann, F.S., Kropec, A., Laverde, D., et al. (2015) In Vitro and in Vivo Activity of Hyperimmune Globulin Preparations against Multiresistant Nosocomial Pathogens. Infection, 43, 169-175.
https://doi.org/10.1007/s15010-014-0706-1
|